Holding(s) in Company
Summary by AI BETAClose X
TR-1: Standard form for notification of major holdings
LONDON, 20 October 2026 – Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75)
(LSE: HIK) (NasdaqDubai: HIK) announces as follows:
|
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i | |||||||||||||||
|
| |||||||||||||||
|
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: |
Hikma Pharmaceuticals Public Limited Company | ||||||||||||||
|
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) | |||||||||||||||
|
Non-UK issuer |
| ||||||||||||||
|
2. Reason for the notification (please mark the appropriate box or boxes with an “X”) | |||||||||||||||
|
An acquisition or disposal of voting rights |
|||||||||||||||
|
An acquisition or disposal of financial instruments |
|||||||||||||||
|
An event changing the breakdown of voting rights |
|||||||||||||||
|
Other (please specify)iii: |
|||||||||||||||
|
3. Details of person subject to the notification obligationiv | |||||||||||||||
|
Name |
|||||||||||||||
|
City and country of registered office (if applicable) |
Boston, United States | ||||||||||||||
|
4. Full name of shareholder(s) (if different from 3.)v | |||||||||||||||
|
Name |
BEST INVESTMENT CORP-WELLINGTON GHC VIDACOS NOMINEES LIMITED State Street Nominees Limited ROY Nominees Limited Nortrust Nominees Limited Mellon Nominees (UK) Ltd. JP Morgan Chase Nominees Limited HSBC Global Custody Nominee (UK) Limited Euroclear Nominees Limited BBH ISL NOMINEES LTD
| ||||||||||||||
|
City and country of registered office (if applicable) |
| ||||||||||||||
|
5. Date on which the threshold was crossed or reachedvi: |
|||||||||||||||
|
6. Date on which issuer notified (DD/MM/YYYY): |
|||||||||||||||
|
7. Total positions of person(s) subject to the notification obligation | |||||||||||||||
|
|
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuervii | |||||||||||
|
Resulting situation on the date on which threshold was crossed or reached |
4.970000
|
0.050000
|
5.020000
|
10483389
| |||||||||||
|
Position of previous notification (if applicable) |
5.050000 |
0.050000 |
5.100000 |
| |||||||||||
|
|
|
|
|
| |||||||||||
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii | |||||||||||||||
|
A: Voting rights attached to shares | |||||||||||||||
|
Class/type of ISIN code (if possible) |
Number of voting rightsix |
% of voting rights | |||||||||||||
|
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) |
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) |
Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | ||||||||||||
|
GB00B0LCW083 |
|
10367479 |
|
4.970000 | |||||||||||
|
|
|
|
|
| |||||||||||
|
SUBTOTAL 8. A |
10367479 |
4.970000% | |||||||||||||
|
| |||||||||||||||
|
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | |||||||||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights | |||||||||||
|
Sub Total 8.B1 |
|
|
|
| |||||||||||
|
| |||||||||||||||
|
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) | |||||||||||||||
|
Type of financial instrument |
Expiration |
Exercise/ |
Physical or cash settlementxii |
Number of voting rights |
% of voting rights | ||||||||||
|
Equity swap |
05/05/2028 |
05/05/2028 |
Cash |
92594 |
0.040000 | ||||||||||
|
Equity Swap |
20/05/2033 |
20/05/2033 |
Cash |
23316 |
0.010000 | ||||||||||
|
Sub Total 8.B2 |
|
|
|
115910 |
0.050000%
| ||||||||||
|
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”) | |
|
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii |
|
|
Full chain of controlled undertakings through which the voting rights and/or the |
X |
|
| |
|
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
Wellington Management Group LLP (Chain 1) |
Wellington Group Holdings LLP |
4.970000 |
|
5.020000% |
|
Wellington Management Group LLP (Chain 1) |
Wellington Investment Advisors Holdings LLP |
4.970000 |
|
5.020000% |
|
Wellington Management Group LLP (Chain 1) |
Wellington Management Global Holdings, Ltd. |
|
|
|
|
Wellington Management Group LLP (Chain 1) |
Wellington Management Europe GmbH |
|
|
|
|
Wellington Management Group LLP (Chain 2) |
Wellington Group Holdings LLP |
4.970000 |
|
5.020000% |
|
Wellington Management Group LLP (Chain 2) |
Wellington Investment Advisors Holdings LLP |
4.970000 |
|
5.020000% |
|
Wellington Management Group LLP (Chain 2) |
Wellington Management Company LLP |
|
|
|
|
Place of completion |
London, UK |
|
Date of completion |
20-Oct-2026
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 51 seconds ago M&G
- 9 minutes ago Frasers Group
- 15 minutes ago BT Group
- 28 minutes ago CLS Holdings
- 35 minutes ago British American Tobacco